Patency of Autologous Reverse Great Saphenous Vein Versus Polytetrafluroethylene in Below Knee Femoro popliteal Bypass Grafting

摘要

A total of 200 bypasses were performed in 190 patients. Of these, 102 (51%) patients had reverse saphenous vein bypass (RSVB) graft and 98 (49%) received expanded polytetrafluroethylene (e-PTFE) graft. Common indications of operation were intermittent claudication in 101 (50.5%) and rest pain in 70 (35%) patients. At 3 year post surgery seven (3.7%) patients were lost to follow-up and 36 (19%) died. Primary patency rate for e-PTFE graft was 62.9% while it was 86.4% for RSVB graft (p =0.032). The secondary patency rate in e-PTFE graft was 64.1% and in RSVB graft 85.1% (P = 0.034).